This episode features Matt Wolf, leader of the healthcare valuation process and a Senior Analyst at RSM. Here, he discusses if we will see more exits or investments in 2021.
No transcript available.
This episode features Matt Wolf, leader of the healthcare valuation process and a Senior Analyst at RSM. Here, he discusses if we will see more exits or investments in 2021.